Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Invitation to offer for National Framework Agreement for the Supply of Generic Pharmaceuticals - Tenofovir Disoproxil/Emtricitabine and Tenofovir Disoproxil/Emtricitabine/Efavirenz
Offer reference number: CM/PHG/17/5545
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months
Potential periods of call-offs under the framework agreement:
North West London: 21/05/2019 to 31/10/2020 (18 months)
North Central and East London: 21/05/2019 to 31/10/2020 (18 months)
South East and West London: 21/05/2019 to 31/10/2020 (18 months)
North of England: 21/05/2019 to 31/10/2020 (18 months)
Midlands and East: 21/05/2019 to 31/10/2020 (18 months)
South of England: 21/05/2019 to 31/10/2020 (18 months)
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Please see list of awarded suppliers (Including SME status) at t | - | £6,500,000 | - |